Home
About Us
Who we are
Founders and Chairs
Individual Members
Emeritus Members
Corporate and Research Members
Cambridge Angels Team
Infographic
Entrepreneurs
Why Cambridge Angels?
Is Angel Investing right for you?
Investment Criteria
Application Process
Apply
Angels
Membership Information
Member portal
Angel Interviews
Portfolio
Current Portfolio
Exits
Cambridge Angels Founded Companies
Portfolio facts
Portfolio Interviews
Apply to Cambridge Angels
News
Portfolio News
Ecosystem News

Welcome to the Cambridge Angels

Home
About Us
Who we are
Founders and Chairs
Individual Members
Emeritus Members
Corporate and Research Members
Cambridge Angels Team
Infographic
Entrepreneurs
Why Cambridge Angels?
Is Angel Investing right for you?
Investment Criteria
Application Process
Apply
Angels
Membership Information
Member portal
Angel Interviews
Portfolio
Current Portfolio
Exits
Cambridge Angels Founded Companies
Portfolio facts
Portfolio Interviews
Apply to Cambridge Angels
News
Portfolio News
Ecosystem News
Funders back Spirea’s novel payload flexibility for cancer therapeutics
17 December 2020
Emmi Nicholl
Funders back Spirea’s novel payload flexibility for cancer therapeutics
Emmi Nicholl
17 December 2020

Funders back Spirea’s novel payload flexibility for cancer therapeutics

Emmi Nicholl
17 December 2020

Source:https://www.businessweekly.co.uk/tech-trail/investment-tree/funders-back-spirea%E2%80%99s-novel-payload-flexibility-cancer-therapeutics

Newer Post007: Angel investing in healthtech with Pam Garside.
Older PostCambridge turns light bulb moments into lightning storm
LI-In-Bug_small.png
Back to Top
Privacy
info@cambridgeangels.net